Compounds > adamantane
Page last updated: 2024-08-21

adamantane and Hemorrhagic Fever, Ebola

adamantane has been researched along with Hemorrhagic Fever, Ebola in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaudhari, HK; Mali, SN1
Bruchez, A; Chandran, K; Côté, M; Cunningham, J; Filone, CM; Hensley, L; Lee, K; Li, Q; Misasi, J; Ory, D; Ren, T1

Other Studies

2 other study(ies) available for adamantane and Hemorrhagic Fever, Ebola

ArticleYear
Molecular modelling studies on adamantane-based Ebola virus GP-1 inhibitors using docking, pharmacophore and 3D-QSAR.
    SAR and QSAR in environmental research, 2019, Volume: 30, Issue:3

    Topics: Adamantane; Drug Design; Ebolavirus; Hemorrhagic Fever, Ebola; Models, Molecular; Molecular Docking Simulation; Quantitative Structure-Activity Relationship

2019
Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection.
    Nature, 2011, Aug-24, Volume: 477, Issue:7364

    Topics: Adamantane; Animals; Antiviral Agents; Carrier Proteins; Cathepsins; Cell Line; Chlorocebus aethiops; Ebolavirus; Endosomes; Glycoproteins; Hemorrhagic Fever, Ebola; Humans; Intracellular Signaling Peptides and Proteins; Membrane Fusion; Membrane Glycoproteins; Molecular Weight; Niemann-Pick C1 Protein; Piperazines; Vero Cells; Viral Fusion Proteins; Virus Internalization

2011